IP ASSIGNMENT AND LICENSE AGREEMENTIp Assignment and License Agreement • July 8th, 2022
CERTAIN IDENTIFIED INFORMATION HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS NOT MATERIAL AND (I) WOULD BE COMPETITIVELY HARMFUL TO THE REGISTRANT IF PUBLICLY DISCLOSED OR (II) IS INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL....Ip Assignment and License Agreement • May 10th, 2022 • Silk Road Medical Inc • Surgical & medical instruments & apparatus • California
This IP Assignment and License Agreement (the “Agreement”), dated and effective as of May 12, 2016 (the “Effective Date”), is entered into by and between Route 92 Medical, Inc., a Delaware corporation with offices at 106 Allen Road, Suite 207, Basking Ridge, New Jersey 07920 (“Route 92”) and NeuroCo, Inc., a Delaware corporation with offices at 735 N. Pastoria Ave., Sunnyvale, California 94085 (“NeuroCo”). Route 92 and NeuroCo are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
IP ASSIGNMENT AND LICENSE AGREEMENTIp Assignment and License Agreement • November 17th, 2021
This IP assignment and license agreement (the Agreement) is dated [...] and is between [Company's name], registry code: [...], address [...], e-mail address [...] (the Company) and [insert IP owner's name], personal identification code: [...], address [...], e-mail address [...] (the Assignor) (collectively the Parties, each a Party). This Agreement comprises the Outlined Terms in Section 1, the Detailed Terms in Section 2 and the Schedules named herein
IP ASSIGNMENT AND LICENSE AGREEMENTIp Assignment and License Agreement • June 1st, 2017
This IP assignment and license agreement (the “Agreement”) is entered into between [Company’s name], registry code: [insert], address [insert], e-mail address [insert] (the “Company”) and [insert IP owner’s name], personal identification code: [insert], address [insert], e-mail address [insert] (the “Assignor”) (collectively the “Parties”, each a “Party”). This Agreement comprises the Outlined Terms in Section 1, the Detailed Terms in Section 2 and the Schedules named herein
